abstract |
The invention relates to benzamides of general formula (I) and their tautomeric forms, as well as to possible enantiomeric and diastereomeric forms, to their E and Z forms and to possible physiologically compatible salts, where the variables R1, R2, R3, A and B have the meanings given in claim 1. The invention also relates to their use as inhibitors of cysteine proteases. |